Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution |
| BNF code | 0905013G0AADFDF |
| Virtual Therapeutic Moiety | Magnesium glycerophosphate |
| Abbreviated name | Mag glycerophos (mag 121.25mg/5ml (5mmol/5ml)) soln |
| Basis of preferred name | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Continuous |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Magnesium glycerophosphate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 72717003 |
| Strength value numerator | 24.250 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | solution.oral |
| Dose Form | |
| Formulation | Oral solution |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| MagnaPhos 121.25mg/5ml (5mmol/5ml) oral solution (TriOn Pharma Ltd) | |
| Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution (Special Order) | |
| Virtual Medicinal Product Packs | |
| Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 1 ml | |
| Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral solution 200 ml | |
dm+d data retrieved from TRUD: release NHSBSA_2.0.0_20250203000001, imported on 4th February 2025 at 03:53:58.